Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 363Active not recruiting 115Terminated 112Recruiting 87Unknown 64Withdrawn 45Not yet recruiting 16No longer available 3Suspended 2Enrolling by invitation 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2

Conditions

Multiple Myeloma 2

Interventions

daratumumab 2Dexamethasone 2vactosertib 1selinexor 1pomalidomide 1mirdametinib 1fludarabine phosphate 1carfilzomib 1aldesleukin 1Specimen Handling 1Sirolimus 1Melphalan 1Lenalidomide 1Interleukin-2 1IL32 protein, human 1Cyclophosphamide 1Calcium Dobesilate 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × Multiple Myeloma × Dexamethasone × Clear all
NCT06348147 2026-05-04

Dara-RVd Induction for Newly Diagnosed Multiple Myeloma With Autologous Stem Cell Transplantation

UNC Lineberger Comprehensive Cancer Center

Phase 2 Suspended
39 enrolled
Plasma cell

Multiple Myeloma

NCT04661137 2026-02-10

A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma

Hackensack Meridian Health

Phase 2 Suspended
96 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡